CrossFirst Bankshares, Inc.

NASDAQ:CFB

17.34 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 128.687124.441122.3661.10860.31862.6380.07753.47550.9148.05748.24140.69648.15345.26144.48643.3943.79140.32339.36538.99836.9735.2533.50630.32427.67825.11
Cost of Revenue 000000000000000.00800000000000
Gross Profit 128.687124.441122.3661.10860.31862.6380.07753.47550.9148.05748.24140.69648.15345.26144.47843.3943.79140.32339.36538.99836.9735.2533.50630.32427.67825.11
Gross Profit Ratio 11111111111111111111111111
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 1.08325.49123.6823.96425.94224.15322.99919.15517.80818.67817.17816.32616.57714.70415.87515.72415.04315.40614.58514.55815.33115.4278.47113.47518.93913.686
Selling & Marketing Expenses 0.4910.5580.8920.5930.6490.7520.9540.7960.7570.6920.7560.5960.4350.3030.3490.1470.2230.50.6850.580.4770.7130.7090.5270.6990.756
SG&A 1.57426.04924.57224.55726.59124.90523.95319.95118.56519.3717.93416.92217.01215.00716.22415.87115.26615.90615.2715.13815.80816.149.1814.00219.63814.442
Other Expenses -11.358-10.485-11.494-64.24-66.643-28.09819.612-35.881-43.772-41.766-33.892-25.448-17.193051.8800000-21.724-23.909-19.093-25.241-37.236-28.606
Operating Expenses 11.35810.48511.494-39.683-40.052-3.19343.565-15.93-25.207-22.396-15.958-8.5261.5731.0855.4371.2791.5181.171-51.3611.007-5.916-7.769-9.913-11.239-17.598-14.164
Operating Income 26.26626.089110.86621.42520.26659.44543.64237.54525.70325.66132.28332.1724.99621.97917.87618.6291.87820.1327.42733.61831.05427.48123.59719.08510.0810.946
Operating Income Ratio 0.2040.210.9060.3510.3360.949566.7790.7020.5050.5340.6690.790.5190.4860.4020.4290.0430.4990.6970.8620.840.780.7040.6290.3640.436
Total Other Income Expenses Net 23.48523.02322.28921.42520.266-39.316-28.348-15.855-6.131-4.645-5.757-5.51-6.156-7.036-7.997-9.125-10.097-15.98-29.297-20.642-19.318-17.712-14.753-11.807-10.958-8.994
Income Before Tax 23.48523.02322.28921.42520.26620.12915.29421.6919.57221.01626.52626.6618.8414.9439.8799.504-8.2194.1514.1312.97611.7369.7698.8447.278-0.8781.952
Income Before Tax Ratio 0.1820.1850.1820.3510.3360.321198.6230.4060.3840.4370.550.6550.3910.330.2220.219-0.1880.1030.3590.3330.3170.2770.2640.24-0.0320.078
Income Tax Expense 4.8634.84.6384.5624.2194.0213.3484.414.0274.1885.7255.663.2632.9081.7851.498-0.8630.2932.7462.5922.2970.419-1.490.924-1.156-0.672
Net Income 18.62218.22317.65116.86316.04716.10811.94617.2815.54516.82820.8012115.57712.0358.0948.006-7.3563.85711.38410.3849.4399.1759.8095.8290.2782.624
Net Income Ratio 0.1450.1460.1440.2760.2660.257155.1430.3230.3050.350.4310.5160.3230.2660.1820.185-0.1680.0960.2890.2660.2550.260.2930.1920.010.105
EPS 0.380.360.350.340.330.330.250.350.310.330.410.410.30.230.160.15-0.140.070.220.220.180.180.230.110.0060.051
EPS Diluted 0.370.360.350.340.330.330.240.350.310.330.40.410.30.230.150.15-0.140.070.220.210.180.180.230.110.0060.051
EBITDA 0.906-3.2211.46322.34722.5961.76345.23138.78726.93626.90233.5533.44826.33623.35419.2419.933.1721.42517.43434.03132.38628.85224.97320.45911.09911.852
EBITDA Ratio 0.007-0.0260.0120.3660.3750.986587.4160.7250.5290.560.6950.8220.5470.5160.4320.4590.0720.5310.4430.8730.8760.8180.7450.6750.4010.472